Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wockhardt Ltd Board/Management Information 2022

Aug 4, 2022

59231_rns_2022-08-04_a43ef135-4f33-40bb-94d4-eb8cc7541b66.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

4[th] August, 2022

Ref. No.: WOCK/SEC/SE/2022-23/027

==> picture [178 x 49] intentionally omitted <==

BSE Limited National Stock Exchange of India Limited
Corporate Relations Department Exchange Plaza
P J Towers Bandra Kurla Complex
Dalal Street Bandra (E)
Mumbai - 400 001 Mumbai - 400 051
Scrip Code: 532300 NSE Symbol: WOCKPHARMA

Dear Sir/Madam,

Sub: Pursuant to Regulation 29 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Intimation of the Meeting of Board of Directors of Wockhardt Limited (‘the Company’)

We wish to inform you that pursuant to Regulation 29 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on 12[th] August, 2022, inter-alia , to consider and approve:

  • (i) the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30[th] June, 2022; and

In view of the above, the Trading window for dealing in the Shares of the Company, which was closed from 1[st] June, 2022 shall remain closed until 48 hours after the declaration of Financial Results on 12[th] August, 2022.

Kindly take the above information on record.

Thanking you,

For Wockhardt Limited

==> picture [115 x 56] intentionally omitted <==

Debashis Dey Company Secretary

==> picture [113 x 49] intentionally omitted <==

==> picture [513 x 32] intentionally omitted <==